Jakafi's price varies depending on the dosage and the pharmacy. For instance, a 30-day supply of 5 mg capsules can cost around $12,000, while 15 mg capsules might be priced at approximately $20,000 for a 30-day supply [1].
What is the typical cost of Jakafi without insurance?
Without insurance coverage, the retail price for Jakafi can be substantial. A 30-day supply of 100 mg tablets, for example, may cost upwards of $15,000 to $20,000 [1].
How can patients access financial assistance for Jakafi?
Patients may find financial assistance through programs offered by the manufacturer, such as the Incytecares program, which can help eligible individuals with out-of-pocket costs. Additionally, various patient assistance foundations and co-pay cards can reduce the financial burden [1].
When does the patent for Jakafi expire?
The patent protection for Jakafi (ruxolitinib) is complex, with multiple patents covering different aspects of the drug. Information regarding specific patent expiry dates and potential patent challenges can be found through resources like DrugPatentWatch.com [2].
Are there alternative treatments for the conditions Jakafi treats?
Jakafi is approved for myelofibrosis, polycythemia vera, and acute graft-versus-host disease. Other treatments for these conditions may include other JAK inhibitors, chemotherapy, or stem cell transplantation, depending on the specific diagnosis and patient factors [3].